The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

OBJECTIVE To assess the relationship between nondiabetic glucose levels and cardio vascular risk. RESEARCH DESIGN AND METHODS Three independent searches using MEDLINE (1966-1996), followed by a manual search of the references from each retrieved article, were conducted by two physicians and one medical librarian. Data had to be reported in at least three quantiles or intervals so that the nature of the relationship between glucose and cardiovascular events (i.e., linear or nonlinear) could be explored, and to ensure that any incremental cardiovascular risk was consistent across quantiles or intervals. RESULTS Analyzed studies comprised 95,783 people (94% male) who had 3,707 cardiovascular events over 12.4 years (1,193,231 person-years). Studies reporting fasting glucose levels (n = 6), 2-h glucose levels (n = 7), 1-h glucose levels (n = 5), and casual glucose levels (n = 4) were included. The glucose load used varied from 50 to 100 g. The highest glucose interval for most studies included glucose values in the diabetic range. The relationship between glucose levels and the risk of a cardiovascular event was modeled for each study and the beta-coefficients were combined. Compared with a glucose level of 4.2 mmol/l (75 mg/dl), a fasting and 2-h glucose level of 6.1 mmol/dl (110 mg/dl) and 7.8 mmol/l (140 mg/dl) was associated with a relative cardiovascular event risk of 1.33 (95% CI 1.06-1.67) and 1.58 (95% CI 1.19-2.10), respectively. CONCLUSIONS The progressive relationship between glucose levels and cardiovascular risk extends below the diabetic threshold.

[1]  J. Medalie,et al.  Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. , 1993, Cardiology.

[2]  E. Casiglia,et al.  Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects. Ten-year mortality and morbidity in the CASTEL study. CArdiovascular STudy in the ELderly. , 1996, Acta diabetologica.

[3]  B. Kirkwood,et al.  Adult male all-cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. , 1988, International journal of epidemiology.

[4]  E. Barrett-Connor,et al.  Is Insulin Really a Heart Disease Risk Factor? , 1995, Diabetes Care.

[5]  E. Barrett-Connor,et al.  GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo Study , 1996, Diabetes Care.

[6]  A. Krolewski,et al.  Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[7]  A. Dyer,et al.  Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry Study , 1997, Diabetes Care.

[8]  E. Barrett-Connor,et al.  Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. , 1991, American journal of epidemiology.

[9]  A. Dyer,et al.  Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. , 1979, Journal of chronic diseases.

[10]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[11]  E. Barrett-Connor,et al.  Is borderline fasting hyperglycemia a risk factor for cardiovascular death? , 1984, Journal of chronic diseases.

[12]  A. Reunanen,et al.  Glucose tolerance and coronary heart disease in middle-aged Finnish men: Social Insurance Institution's Coronary Heart Disease Study. , 1979, Journal of chronic diseases.

[13]  P Ducimetière,et al.  Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. , 1993, BMJ.

[14]  M. Schroll,et al.  Relationship of fasting blood glucose to prevalence of ECG abnormalities and 10 yr risk of mortality from cardiovascular diseases in men born in 1914: from the Glostrup population studies. , 1979, Journal of chronic diseases.

[15]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[16]  L. Wilhelmsen,et al.  Fasting Blood Glucose and Risk of Coronary Heart Disease, Stroke, and All‐cause Mortality: A 17‐year Follow‐up Study of Men Born in 1913 , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[17]  D. Singer,et al.  Association of HbA1c With Prevalent Cardiovascular Disease in the Original Cohort of the Framingham Heart Study , 1992, Diabetes.

[18]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[19]  E. Feskens,et al.  Glucose tolerance and the risk of cardiovascular diseases: The zutphen study , 1992 .

[20]  R. Klein,et al.  The association of glycemia and cause-specific mortality in a diabetic population. , 1994, Archives of internal medicine.

[21]  L. Kuller,et al.  Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. , 1991, Preventive medicine.

[22]  V. Grabauskas Glucose Intolerance as Contributor to Noncommunicable Disease Morbidity and Mortality: WHO Integrated Program for Community Health in Noncommunicable Diseases , 1988, Diabetes Care.

[23]  P. Sorlie,et al.  Abnormal Blood Glucose and Coronary Heart Disease: The Puerto Rico Heart Health Program , 1983, Diabetes Care.

[24]  N. Ahmed,et al.  Glycation and diabetic complications. , 1991, JPMA. The Journal of the Pakistan Medical Association.

[25]  A Whitehead,et al.  A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.

[26]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[27]  T. Lyons,et al.  Lipoprotein glycation and its metabolic consequences. , 1997, Diabetes.

[28]  T. Lyons,et al.  Glycation and oxidation: a role in the pathogenesis of atherosclerosis. , 1993, The American journal of cardiology.

[29]  T. Welborn,et al.  Busselton population study: risk associated with asymptomatic hyperglycemia. , 1979, Journal of chronic diseases.

[30]  S. Yusuf,et al.  Dysglycaemia and risk of cardiovascular disease , 1996, The Lancet.

[31]  G. Viberti A glycemic threshold for diabetic complications? , 1995, The New England journal of medicine.

[32]  R. Jarrett The cardiovascular risk associated with impaired glucose tolerance. , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[33]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[34]  J. Tuomilehto,et al.  The Effect of Diabetes and Impaired Glucose Tolerance on Mortality in Malta , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[35]  W. Gilmour,et al.  Relationship of glucose to prevalence of ECG abnormalities at baseline and to 6-yr mortality in Scottish males aged 45-64 yr. , 1979, Journal of chronic diseases.

[36]  K. Svärdsudd,et al.  Long-Term Glycemic Control Relates to Mortality in Type II Diabetes , 1995, Diabetes Care.

[37]  I. Holme,et al.  Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. , 1995, Stroke.

[38]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[39]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.